No association between anxiety disorders and catechol-O-methyltransferase polymorphism

Area of Science:

• Genetics
• Psychiatry
• Molecular Biology

Background:

• Increased morbidity risk for anxiety disorders observed in relatives of obsessive-compulsive disorder (OCD) patients.
• A recent study reported a significant association between a catechol-O-methyltransferase (COMT) gene polymorphism and OCD.

Purpose of the Study:

• To investigate the potential association between the COMT gene polymorphism and anxiety disorders.
• To determine if COMT gene variations contribute to the development of anxiety disorders.

Main Methods:

• An association study was conducted involving 108 patients diagnosed with anxiety disorders and 135 healthy Japanese controls.
• Genotypic and allelic frequencies of the COMT polymorphism were analyzed and compared between patient and control groups.
• Statistical analyses examined differences based on diagnostic subgroups, gender, family history, and age of onset.

Main Results:

• No statistically significant differences were found in genotypic or allelic frequencies of the COMT polymorphism between anxiety disorder patients and healthy controls.
• The COMT polymorphism showed no significant association with gender, family history, or age of onset in the studied population.
• Subgroup analyses did not reveal any significant genetic links between the COMT polymorphism and specific anxiety disorder diagnoses.

Conclusions:

• The functional COMT polymorphism does not appear to be a significant contributing factor to anxiety disorders in the Japanese population.
• Further research may be needed to explore other genetic or environmental factors influencing anxiety disorder development.
• These findings help refine our understanding of the genetic underpinnings of anxiety disorders.